🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.01
-0.18 (-1.77%)
Nov 19, 2026, 4:00 PM EST - Market closed

Corvus Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8445753448640112
Market Cap Growth
24.37%67.27%298.31%118.11%-64.73%12.29%
Enterprise Value
64251030256-740
Last Close Price
10.017.705.351.760.852.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.059.4010.562.230.711.16
P/TBV Ratio
4.059.4010.562.230.711.16

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.020.030.040.050.04
Net Debt / Equity Ratio
-0.97-0.91-1.56-0.67-0.71-0.68
Net Debt / EBITDA Ratio
2.991.301.851.111.261.74
Net Debt / FCF Ratio
4.221.692.001.081.461.79
Quick Ratio
13.256.091.473.963.997.22
Current Ratio
13.386.211.544.074.067.36
Return on Equity (ROE)
-45.92%-32.60%-174.85%-57.02%-53.90%-51.08%
Return on Assets (ROA)
-27.83%-38.36%-30.09%-25.63%-22.50%-24.61%
Return on Capital Employed (ROCE)
-32.50%-69.60%-82.20%-60.30%-55.60%-38.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.21%-2.66%-18.12%-31.32%-104.39%-38.55%
FCF Yield
-5.68%-5.73%-7.40%-27.77%-68.97%-32.73%
Buyback Yield / Dilution
-18.80%-30.76%-26.99%-3.16%-11.23%-41.98%
SEC Filings: 10-K · 10-Q